New Phase 1 Findings Show Promise of Cancer Vaccines in KRAS Mutations

TARGETED ONCOLOGY: Innovative findings in the field of cancer vaccines were presented at the Society for Immunotherapy of Cancer (SITC), focusing on a novel technology directing vaccines into lymph nodes.